HAP Trading’s Halozyme HALO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-10,200
Closed -$10K 2115
2022
Q1
$10K Buy
+10,200
New +$363K ﹤0.01% 1780
2020
Q1
Sell
-30,500
Closed -$45K 1324
2019
Q4
$45K Buy
30,500
+8,700
+40% +$151K ﹤0.01% 730
2019
Q3
$35K Buy
21,800
+2,900
+15% +$47.8K ﹤0.01% 811
2019
Q2
$23K Buy
18,900
+6,900
+58% +$111K ﹤0.01% 859
2019
Q1
$15K Buy
12,000
+1,300
+12% +$21.1K ﹤0.01% 874
2018
Q4
$2K Buy
+10,700
New +$171K ﹤0.01% 1065
2017
Q3
Sell
-10,000
Closed -$16K 957
2017
Q2
$16K Buy
+10,000
New +$134K ﹤0.01% 813
2017
Q1
Sell
-98,600
Closed -$145K 1137
2016
Q4
$145K Buy
98,600
+9,000
+10% +$98.6K 0.01% 513
2016
Q3
$276K Buy
89,600
+12,900
+17% +$132K 0.01% 448
2016
Q2
$109K Sell
76,700
-546,700
-88% -$5.39M 0.01% 494
2016
Q1
$1.16M Buy
+623,400
New +$5.87M 0.08% 190
2015
Q4
Sell
-32,900
Closed -$15K 1012
2015
Q3
$15K Buy
+32,900
New +$661K ﹤0.01% 848
2015
Q1
Sell
-128,600
Closed -$58K 1048
2014
Q4
$58K Sell
128,600
-544,800
-81% -$4.84M ﹤0.01% 706
2014
Q3
$529K Buy
673,400
+163,700
+32% +$1.56M 0.02% 457
2014
Q2
$867K Buy
509,700
+447,400
+718% +$3.8M 0.03% 348
2014
Q1
$50K Sell
62,300
-37,700
-38% -$560K ﹤0.01% 783
2013
Q4
$189K Buy
+100,000
New +$1.29M 0.01% 722

Other funds holding HALO

HAP Trading's HALO Position: Q2 2017 in Review

HAP Trading sold out of Halozyme (HALO) in Q2 2017, closing a stake of 37,059 shares — an estimated $495K sold.

HAP Trading first reported a position in HALO in Q1 2017 and held it in 1 quarter. The position peaked at $480K in Q1 2017. 167 funds tracked by Wall St. Rank hold HALO as of Q2 2017.

  • HAP Trading reported no remaining Halozyme position as of Q2 2017 after selling out during the quarter.
  • HAP Trading sold 37,059 Halozyme shares in Q2 2017, an estimated $495K.
  • HAP Trading first reported a position in Halozyme in Q1 2017 and held it in 1 quarter.
  • HAP Trading's Halozyme position peaked at $480K in Q1 2017.
  • 167 funds tracked by Wall St. Rank held Halozyme as of Q2 2017.

Based on HAP Trading's 13F filing for Q2 2017, filed 10 Aug 2017.